1. Heaney, RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. American Journal of Clinical Nutrition 2004; 80: 1706S–1709S.
2. Visser, M, Deeg, DJ, Lips, P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. Journal of Clinical Endocrinology and Metabolism 2003; 88: 5766–5772.
3. Bertone-Johnson, ER, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiology Biomarkers & Prevention 2005; 14: 1991–1997.
4. Lappe, JM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. American Journal of Clinical Nutrition 2007; 85: 1586–1591.
5. Freedman, DM, Dosemeci, M, McGlynn, K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occupational & Environmental Medicine 2002; 59: 257–262.
6. Schmidt-Gayk, H., et al. Serum 25-hydroxycalciferol in myocardial infarction. Atherosclerosis 1977; 26: 55–58.
7. Cutolo, M, et al. Vitamin D in rheumatoid arthritis. Autoimmunity Reviews 2007; 7: 59–64.
8. Cutolo, M, Otsa, K. Vitamin D, immunity and lupus [Review]. Lupus 2008; 17: 6–10.
9. Wang, TT, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 2004; 173: 2909–2912.
10. Klotman, ME, Chang, TL. Defensins in innate antiviral immunity. Nature Reviews Immunology 2006; 6: 447–456.
11. Leikina, E, et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nature Immunology 2005; 6: 995–1001.
12. Liu, PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770–1773.
13. Harris, SS, Dawson-Hughes, B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. American Journal of Clinical Nutrition 1998; 67: 1232–1236.
14. Hope-Simpson, RE, Golubev, DB. A new concept of the epidemic process of influenza A virus. Epidemiology and Infection 1987; 99: 5–54.
15. Hope-Simpson, RE. The Transmission of Epidemic Influenza. New York: Plenum Press, 1992.
16. Fendrick, AM, et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives of Internal Medicine 2003; 163: 487–494.
18. Lemire, JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. Journal of Cell Biochemistry 1992; 49: 26–31.
19. Schleithoff, SS, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. American Journal of Clinical Nutrition 2006; 83: 754–759.
20. Aloia, JF, et al. A randomized controlled trial of vitamin D3 supplementation in African American women. Archives of Internal Medicine 2005; 165: 1618–1623.
21. Institute of Medicine, Food and Nutrition Board. 1999 Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academy Press.
22. Heaney, RP, et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. American Journal of Clinical Nutrition 2003; 77: 204–210.
23. Vieth, R, et al. The urgent need to recommend an intake of vitamin D that is effective. American Journal of Clinical Nutrition 2007; 85: 649–650.
24. Chubak, J, et al. Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. American Journal of Medicine 2006; 119: 937–942.
25. Nieman, DC, et al. Physical activity and immune function in elderly women. Medicine & Science in Sports & Exercise 1993; 25: 823–831.
26. Vieth, R, Chan, PC, MacFarlane, GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. American Journal of Clinical Nutrition 2001; 73: 288–294.
27. Laaksi, I, et al. An association of serum vitamin D concentrations <40 nmol/l with acute respiratory tract infection in young Finnish men. American Journal of Clinical Nutrition 2007; 86: 714–717.
28. Avenell, A, et al. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people [RECORD trial, ISRCTN 51647438]. Age and Ageing 2007; 36: 574–577.
31. Barger-Lux, MJ, et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporosis International 1998; 8: 222–230.
32. Looker, AC, et al. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002; 30: 771–777.
33. Trang, HM, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. American Journal of Clinical Nutrition 1998; 68: 854–858.
34. Houghton, LA, Vieth, R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. American Journal of Clinical Nutrition 2006; 84: 694–697.